Xortx submits orphan drug designation application to the european medicines agency (ema) to treat progressive kidney disease

● xortx's proprietary formulation of oxypurinol – xorlo™ – to treat progressive kidney disease associated with autosomal dominant polycystic kidney disease (adpkd) ●

XRTX Ratings Summary

XRTX Quant Ranking